News

The grant, from the National Institute of Allergy and Infectious Diseases under the National Institutes of Health (NIH), will help Micronics determine whether its rapid nucleic acid test

This patent protects Cytori’s key device technology, which processes adult stem and regenerative cells from adipose tissue at the patient’s bedside. The new US patent is a central

This first-in-man trial is a prospective, multi-center, single-blind, randomized, controlled study using the Cinatra voclosporin-coated coronary stent system, which will be compared to Atrium’s Cinatra bare metal coronary

Under the agreement, TapImmune has the option to acquire three follow-on technologies developed at the University of British Columbia (UBC) that fall under the scope of the original

Both PharmaLink and Matrix Contract Research have been providing contract research services for biotechnology, pharmaceutical and device companies for approximately 10 years. The two companies have partnered together

Kardia said that the move provides a more comprehensive line of high performance products and services for cardiology. With this acquisition, Kardia expects to offer customers a complete

Zaleplon capsules are the generic version of King Pharmaceuticals’s Sonata capsules, which had US sales of approximately $88 million for the 12 months ended March 31, 2008, according

The marketing authorization application (MAA) was filed with Swissmedic by Sucampo Pharmaceuticals’s branch office in Basel, Switzerland. The submission is part of the ongoing development of Amitiza 24mcg

The international, double-blind, placebo-controlled safety and efficacy study of oral Dimebon is known as the Connection study. The Connection study will enroll approximately 525 patients with mild-to-moderate Alzheimer’s